| Affiliation: | 1. Duke Cancer Institute, Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina;2. University of Chicago, Chicago, Illinois;3. University of Michigan Medical Center, Ann Arbor, Michigan;4. Johns Hopkins University, Baltimore, Maryland;5. University of Pittsburgh, Pittsburgh, Pennsylvania;6. Oregon Health and Science University Center for Health, Portland, Oregon;7. Rocky Mountain Cancer Centers, Aurora, Colorado;8. Virginia Oncology Associates, Norfolk, Virginia;9. Lineberger Comprehensive Cancer Center, University of North Carolina–Chapel Hill, Chapel Hill, North Carolina;10. Ohio State University Comprehensive Cancer Center, Columbus, Ohio;11. Carolina Urologic Research Center, Myrtle Beach, South Carolina;12. Dana-Farber Cancer Institute, Boston, Massachusetts;13. Merck & Co, Inc, North Wales, Pennsylvania;14. Acerta Pharma (a member of the AstraZeneca group), South San Francisco, California;15. Division of Surgical Sciences, Department of Surgery, Duke University Medical Center, Durham, North Carolina;16. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, North Carolina;17. Duke Cancer Institute, Division of Medical Oncology, Department of Medicine, Duke University Medical Center, Durham, North Carolina Duke Clinical Research Institute, Durham, North Carolina |
